专访|细胞补充剂能否改善肝功能?

2021-04-22 K.K MedSci原创

NAD是一种存在于人体每个细胞中的辅酶,是细胞能量的重要来源,有助于维持健康的线粒体功能,或帮助人类实现健康地变老。

近日,细胞出版社(Cell Press)旗下的预印本期刊《SneakPeek》上发表的一项临床研究显示,联合代谢辅助因子(CMCS)补充治疗可大幅降低非酒精性脂肪肝患者体内的血清丙氨酸转氨酶(39%)、天冬氨酸转氨酶(30%)及尿酸(12%)水平,从而显着减少肝脂肪(10%),并改善肝功能。

联合代谢辅助因子补充治疗可减少非酒精性脂肪肝患者的肝脂肪

研究负责人Mardinoglu博士说到:“与安慰剂治疗组相比,仅接受10周的联合代谢辅助因子治疗后,患者的肝脂肪便显着降低,肝功能也得以改善。基于这些研究结果,我们计划设计一项随机、双盲,且经活检验证的临床研究,用于测试代谢辅助因子对伴有肝纤维化和炎症的非酒精性脂肪肝炎(NASH)患者的影响。”这项随机、单盲且有安慰剂对照的II期临床研究以31名25~63岁的肥胖性非酒精性脂肪肝患者为研究对象。研究报告显示,非酒精性脂肪性肝病(NAFLD)患者在接受由烟酰胺核糖(NR)、L-丝氨酸、N-乙酰-L-半(NAC)和左旋肉碱酒石酸盐联合的营养方案治疗后,体内的肝脂肪和炎症标志物明显减少。

对于这项研究取得的结果,ChromaDex公司全球科学与监管事务高级副总裁Andrew Shao博士在接受生物谷采访时表示:“该项初步试验凸显了NR在支持线粒体健康层面的潜在作用,并为进一步检验含NR的联合补充剂营养方案在生理层面的影响奠定了基础。目前已经证明了含NR的营养方案能够对肝脏健康产生积极影响。瑞典皇家理工学院和伦敦国王学院教授Adil Mardinoglu博士将在一项随访临床试验中进一步研究NR对非酒精性脂肪肝(NAFLD)患者的影响。我们已与来自世界各地的研究人员累计开展了超过200个在研项目。这些项目为研究人员进一步实现科学创新提供了相关的材料和数据。我们期待这些在研项目能够进一步证实NR对人类健康的多方面影响。”ChromaDex是一家致力于健康变老的全球性生物科学公司,独有Charles Brenner博士所研发的烟酰胺核糖(NR)的专利许可。

世界卫生组织认为,人类的衰老过程,其实是在分子和细胞层级各种损害的积累造成的。比如,我们25岁时膝盖受到伤害,可能只会出现一点浮肿,但60岁时,同样的伤害可能就会导致关节炎。那么,烟酰胺腺嘌呤二核苷(NAD)在衰老和预防肝脏疾病方面,起着怎样的作用?

图 NR在被身体吸收后能直接进入细胞,而NMN不能  来源:ChromaDex

Andrew Shao博士提到:“NAD是一种存在于人体每个细胞中的辅酶,是细胞能量的重要来源,有助于维持健康的线粒体功能,或帮助人类实现健康地变老。

当ChromaDex公司发现NAD+前体烟酰胺核糖(NR)之后,将其以产品主打成分NIAGEN®烟酰胺核糖的形式进行商业化生产,成为了ChromaDex旗下产品Tru Niagen® 的活性成分。

图 Tru Niagen®

2018年12月份,ChromaDex公司和雀巢健康科学公司还签署了Tru Niagen®的全球商业许可和供应协议。协定主要内容包含:在雀巢的营养品以及消费者健康类的某些产品中加入ChromaDex的专利成分Niagen®(也就是Tru Niagen®的唯一活性成分)。协议的合作国家范围包括北美、欧洲、拉丁美洲、澳大利亚、日本和新西兰。

Andrew Shao博士谈到这项合作时称:“ChromaDex与雀巢达成此项合作对我们而言意义非凡。这项合作让更多人了解了NAD以及健康变老的重要性。”

 
 

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1703363, encodeId=b3431e033634d, content=<a href='/topic/show?id=dba720e31b7' target=_blank style='color:#2F92EE;'>#专访#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20731, encryptionId=dba720e31b7, topicName=专访)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=070a30497323, createdName=flyingeagle87, createdTime=Wed Mar 09 03:49:13 CST 2022, time=2022-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1366741, encodeId=a6c61366e4146, content=<a href='/topic/show?id=8b4181188f5' target=_blank style='color:#2F92EE;'>#肝功能#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=81188, encryptionId=8b4181188f5, topicName=肝功能)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8942242, createdName=jj000001, createdTime=Sat Apr 24 06:49:13 CST 2021, time=2021-04-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=959710, encodeId=7f1f959e10ad, content=鞋习, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201214/b3170121d995432ea306ae3a7809cc05/2cfb236f361b4d3c80ef8fdef4301832.jpg, createdBy=8ad35400531, createdName=ZJYYY7, createdTime=Fri Apr 23 10:24:59 CST 2021, time=2021-04-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=959698, encodeId=edf39596985e, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200720/972f8c2f32a64cd28f904bad3945efc9/3d1556a9e54b4781a5f4968d888e5874.jpg, createdBy=5d015401562, createdName=海明明, createdTime=Fri Apr 23 10:00:06 CST 2021, time=2021-04-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=959469, encodeId=1a669594690b, content=好文章!, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Thu Apr 22 18:14:36 CST 2021, time=2021-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=959420, encodeId=85bc9594201f, content=👍, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=46905128057, createdName=zy&kt, createdTime=Thu Apr 22 16:27:24 CST 2021, time=2021-04-22, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1703363, encodeId=b3431e033634d, content=<a href='/topic/show?id=dba720e31b7' target=_blank style='color:#2F92EE;'>#专访#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20731, encryptionId=dba720e31b7, topicName=专访)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=070a30497323, createdName=flyingeagle87, createdTime=Wed Mar 09 03:49:13 CST 2022, time=2022-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1366741, encodeId=a6c61366e4146, content=<a href='/topic/show?id=8b4181188f5' target=_blank style='color:#2F92EE;'>#肝功能#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=81188, encryptionId=8b4181188f5, topicName=肝功能)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8942242, createdName=jj000001, createdTime=Sat Apr 24 06:49:13 CST 2021, time=2021-04-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=959710, encodeId=7f1f959e10ad, content=鞋习, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201214/b3170121d995432ea306ae3a7809cc05/2cfb236f361b4d3c80ef8fdef4301832.jpg, createdBy=8ad35400531, createdName=ZJYYY7, createdTime=Fri Apr 23 10:24:59 CST 2021, time=2021-04-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=959698, encodeId=edf39596985e, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200720/972f8c2f32a64cd28f904bad3945efc9/3d1556a9e54b4781a5f4968d888e5874.jpg, createdBy=5d015401562, createdName=海明明, createdTime=Fri Apr 23 10:00:06 CST 2021, time=2021-04-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=959469, encodeId=1a669594690b, content=好文章!, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Thu Apr 22 18:14:36 CST 2021, time=2021-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=959420, encodeId=85bc9594201f, content=👍, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=46905128057, createdName=zy&kt, createdTime=Thu Apr 22 16:27:24 CST 2021, time=2021-04-22, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1703363, encodeId=b3431e033634d, content=<a href='/topic/show?id=dba720e31b7' target=_blank style='color:#2F92EE;'>#专访#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20731, encryptionId=dba720e31b7, topicName=专访)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=070a30497323, createdName=flyingeagle87, createdTime=Wed Mar 09 03:49:13 CST 2022, time=2022-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1366741, encodeId=a6c61366e4146, content=<a href='/topic/show?id=8b4181188f5' target=_blank style='color:#2F92EE;'>#肝功能#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=81188, encryptionId=8b4181188f5, topicName=肝功能)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8942242, createdName=jj000001, createdTime=Sat Apr 24 06:49:13 CST 2021, time=2021-04-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=959710, encodeId=7f1f959e10ad, content=鞋习, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201214/b3170121d995432ea306ae3a7809cc05/2cfb236f361b4d3c80ef8fdef4301832.jpg, createdBy=8ad35400531, createdName=ZJYYY7, createdTime=Fri Apr 23 10:24:59 CST 2021, time=2021-04-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=959698, encodeId=edf39596985e, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200720/972f8c2f32a64cd28f904bad3945efc9/3d1556a9e54b4781a5f4968d888e5874.jpg, createdBy=5d015401562, createdName=海明明, createdTime=Fri Apr 23 10:00:06 CST 2021, time=2021-04-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=959469, encodeId=1a669594690b, content=好文章!, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Thu Apr 22 18:14:36 CST 2021, time=2021-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=959420, encodeId=85bc9594201f, content=👍, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=46905128057, createdName=zy&kt, createdTime=Thu Apr 22 16:27:24 CST 2021, time=2021-04-22, status=1, ipAttribution=)]
    2021-04-23 ZJYYY7

    鞋习

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1703363, encodeId=b3431e033634d, content=<a href='/topic/show?id=dba720e31b7' target=_blank style='color:#2F92EE;'>#专访#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20731, encryptionId=dba720e31b7, topicName=专访)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=070a30497323, createdName=flyingeagle87, createdTime=Wed Mar 09 03:49:13 CST 2022, time=2022-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1366741, encodeId=a6c61366e4146, content=<a href='/topic/show?id=8b4181188f5' target=_blank style='color:#2F92EE;'>#肝功能#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=81188, encryptionId=8b4181188f5, topicName=肝功能)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8942242, createdName=jj000001, createdTime=Sat Apr 24 06:49:13 CST 2021, time=2021-04-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=959710, encodeId=7f1f959e10ad, content=鞋习, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201214/b3170121d995432ea306ae3a7809cc05/2cfb236f361b4d3c80ef8fdef4301832.jpg, createdBy=8ad35400531, createdName=ZJYYY7, createdTime=Fri Apr 23 10:24:59 CST 2021, time=2021-04-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=959698, encodeId=edf39596985e, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200720/972f8c2f32a64cd28f904bad3945efc9/3d1556a9e54b4781a5f4968d888e5874.jpg, createdBy=5d015401562, createdName=海明明, createdTime=Fri Apr 23 10:00:06 CST 2021, time=2021-04-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=959469, encodeId=1a669594690b, content=好文章!, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Thu Apr 22 18:14:36 CST 2021, time=2021-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=959420, encodeId=85bc9594201f, content=👍, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=46905128057, createdName=zy&kt, createdTime=Thu Apr 22 16:27:24 CST 2021, time=2021-04-22, status=1, ipAttribution=)]
    2021-04-23 海明明

    学习

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1703363, encodeId=b3431e033634d, content=<a href='/topic/show?id=dba720e31b7' target=_blank style='color:#2F92EE;'>#专访#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20731, encryptionId=dba720e31b7, topicName=专访)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=070a30497323, createdName=flyingeagle87, createdTime=Wed Mar 09 03:49:13 CST 2022, time=2022-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1366741, encodeId=a6c61366e4146, content=<a href='/topic/show?id=8b4181188f5' target=_blank style='color:#2F92EE;'>#肝功能#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=81188, encryptionId=8b4181188f5, topicName=肝功能)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8942242, createdName=jj000001, createdTime=Sat Apr 24 06:49:13 CST 2021, time=2021-04-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=959710, encodeId=7f1f959e10ad, content=鞋习, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201214/b3170121d995432ea306ae3a7809cc05/2cfb236f361b4d3c80ef8fdef4301832.jpg, createdBy=8ad35400531, createdName=ZJYYY7, createdTime=Fri Apr 23 10:24:59 CST 2021, time=2021-04-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=959698, encodeId=edf39596985e, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200720/972f8c2f32a64cd28f904bad3945efc9/3d1556a9e54b4781a5f4968d888e5874.jpg, createdBy=5d015401562, createdName=海明明, createdTime=Fri Apr 23 10:00:06 CST 2021, time=2021-04-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=959469, encodeId=1a669594690b, content=好文章!, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Thu Apr 22 18:14:36 CST 2021, time=2021-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=959420, encodeId=85bc9594201f, content=👍, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=46905128057, createdName=zy&kt, createdTime=Thu Apr 22 16:27:24 CST 2021, time=2021-04-22, status=1, ipAttribution=)]
    2021-04-22 jyzxjiangqin

    好文章!

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=1703363, encodeId=b3431e033634d, content=<a href='/topic/show?id=dba720e31b7' target=_blank style='color:#2F92EE;'>#专访#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20731, encryptionId=dba720e31b7, topicName=专访)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=070a30497323, createdName=flyingeagle87, createdTime=Wed Mar 09 03:49:13 CST 2022, time=2022-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1366741, encodeId=a6c61366e4146, content=<a href='/topic/show?id=8b4181188f5' target=_blank style='color:#2F92EE;'>#肝功能#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=81188, encryptionId=8b4181188f5, topicName=肝功能)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8942242, createdName=jj000001, createdTime=Sat Apr 24 06:49:13 CST 2021, time=2021-04-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=959710, encodeId=7f1f959e10ad, content=鞋习, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201214/b3170121d995432ea306ae3a7809cc05/2cfb236f361b4d3c80ef8fdef4301832.jpg, createdBy=8ad35400531, createdName=ZJYYY7, createdTime=Fri Apr 23 10:24:59 CST 2021, time=2021-04-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=959698, encodeId=edf39596985e, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200720/972f8c2f32a64cd28f904bad3945efc9/3d1556a9e54b4781a5f4968d888e5874.jpg, createdBy=5d015401562, createdName=海明明, createdTime=Fri Apr 23 10:00:06 CST 2021, time=2021-04-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=959469, encodeId=1a669594690b, content=好文章!, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Thu Apr 22 18:14:36 CST 2021, time=2021-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=959420, encodeId=85bc9594201f, content=👍, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=46905128057, createdName=zy&kt, createdTime=Thu Apr 22 16:27:24 CST 2021, time=2021-04-22, status=1, ipAttribution=)]
    2021-04-22 zy&kt

    👍

    0

相关资讯

J Altern Complement Med:针刺和有氧间歇训练均可有效改善非酒精性脂肪肝患者的肝功能,其中针刺的效果更佳

非酒精性脂肪性肝病(NAFLD)是影响肝脏的最常见和最重要的疾病之一,在全世界的发病率越来越高。本研究旨在对比针刺(EA)与有氧间歇训练(AIT)运动的效果,以及它们对非酒精性脂肪肝患者肝功能的影响,

AJG: 体重增加对非肥胖人群非酒精性脂肪肝发病率的影响

非酒精性脂肪肝(NAFLD)是严重的脂肪性肝病之一, NAFLD包括非酒精性脂肪性肝炎(NASH), NASH可以发展为肝硬化和肝癌,目前已经成为肝移植的主要原因。

Stroke:非酒精性脂肪肝严重程度与缺血性卒中风险的关系

NAFLD的严重程度与未来较高的IS事件风险相关。

Clin Trans Gastroenterology: 腹部脂肪组织分布对非酒精性脂肪性肝病和代谢综合征的影响

肥胖是长期热量摄入超过能量消耗的结果,它与代谢综合症的风险增加有关,并且是限制发达国家预期寿命的主要原因之一.

非酒精性脂肪肝相关性肝硬化患者肝功能不全的准确预测模型

非酒精性脂肪肝疾病(NAFLD)是肝硬化和随后并发症的越来越重要的原因。